Jonathan Heseltine

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Metastatic Renal Cell Carcinoma

Epidermal Growth Factor Receptor

Ejection Fraction

Top Venues

Targeted oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Marcus Rathbone, Conor O'Hagan, Helen Wong, Adeel Khan, Timothy Cook, Sarah Rose, Jonathan Heseltine, Carles Escriu
Intracranial Efficacy of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in Real-World Patients with Non-Small-Cell Lung Cancer and EGFR or ALK Alterations. Cancers 16 (7) (2024)
Marcus Rathbone, Conor O'Hagan, Helen Wong, Adeel Khan, Timothy Cook, Sarah Rose, Jonathan Heseltine, Carles Escriu
Intracranial Efficacy of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in Real-World Patients with Non-Small-Cell Lung Cancer and EGFR or ALK Alterations. Cancers 16 (7) (2024)
Marcus Rathbone, Conor O'Hagan, Helen Wong, Adeel Khan, Timothy Cook, Sarah Rose, Jonathan Heseltine, Carles Escriu
Intracranial Efficacy of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in Real-World Patients with Non-Small-Cell Lung Cancer and EGFR or ALK Alterations. Cancers 16 (7) (2024)
Jonathan Heseltine, Jennifer Allison, Sam Wong, Kellati Prasad, Zhu-Chuen Oong, Helen Wong, Andrea Law, Natalie Charnley, Omi Parikh, Tom Waddell, Shien Chow
Clinical Outcomes of Tivozanib Monotherapy as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Multicentric UK Real-World Analysis. Targeted oncology (2023)